$300,000 Grant to be Awarded to Winning Proposal on "Neurodegeneration: Perceptual Consequences and Quantification in Human Subjects - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
$300,000 Grant to be Awarded to Winning Proposal on "Neurodegeneration: Perceptual Consequences and Quantification in Human Subjects


$300,000 Grant to be Awarded to Winning Proposal on "Neurodegeneration: Perceptual Consequences and Quantification in Human Subjects

PR Newswire

SINGAPORE, May 14, 2014 /PRNewswire/ --

SOURCE IRC

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here